Sanofi Halts Zika Vaccine Research But Other Candidate Vaccines Move Forward In Development

CNN: Sanofi stops work on Zika vaccine while others forge forward
“French pharmaceutical giant Sanofi SA paused development of a Zika virus vaccine candidate in response to funding cuts by the U.S. government, the company said in a statement on its website last week. … ‘Right now, there’s no indication that Sanofi is anything other than just sort of an individual situation that doesn’t necessarily impact other companies,’ [NIAID Director Anthony] Fauci said. His institute is working on a number of vaccine candidates based on several approaches…” (Scutti, 9/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.